Design Therapeutics Stock Forecast

Sell candidate since Jul 16, 2026 Gain 0.08%

The Design Therapeutics, Inc. stock price gained 4.99% on the last trading day (Thursday, 30th Jul 2026), rising from $12.02 to $12.62. During the last trading day the stock fluctuated 6.43% from a day low at $12.05 to a day high of $12.82. The price has been going up and down for this period, and there has been a 0.08% gain for the last 2 weeks. Volume fell on the last day by -28 thousand shares and in total, 521 thousand shares were bought and sold for approximately $6.58 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Design Therapeutics, Inc. stock with a 90% probability to be traded between $10.48 and $16.23 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

DSGN Signals & Forecast

There are mixed signals in the stock today. The Design Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $12.99. On a fall, the stock will find some support from the short-term average at $11.94. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Thursday, July 23, 2026, and so far it has risen 8.51%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Design Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $11.10 and $10.70. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Design Therapeutics, Inc. finds support just below today's level at $11.10. If this is broken, then the next support from accumulated volume will be at $10.70 and $10.49.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.775 between high and low, or 6.43%. For the last week, the stock has had daily average volatility of 6.38%.

Design Therapeutics, Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DSGN) For The Upcoming Trading Day Of Friday 31st

For the upcoming trading day on Friday, 31st we expect Design Therapeutics, Inc. to open at $12.50, and during the day (based on 14 day Average True Range), to move between $12.19 and $13.05, which gives a possible trading interval of +/-$0.85 (+/-7.01%) up or down from last closing price. If Design Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.35 (5.78%) than the support at $11.10 (12.04%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Design Therapeutics, Inc. stock A Buy?

Design Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.552 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 31, 2026 - $12.50 ( 0.99%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk